Evolution of the Average Target: DiaSorin S.p.A.

Evolution of the Target Price: DiaSorin S.p.A.

Changes in Analyst Recommendations: DiaSorin S.p.A.

bfc2e36e9d6910ca.zzy2e5eGhHNATanyLYKIkRQu2J1JSuf_kuQ7u7VZ14E.l1DRI9zc3iYHGtzAdeDromd7kNc7B5Gu46py_8E_pMi8c8UY4O3XRgMa3g~368ee9a365a5449c4523806c77161bf4
08-12 UBS Downgrades DiaSorin to Sell Rating, Cuts PT MT
08-04 Intermonte Upgrades DiaSorin to Outperform, Boosts PT MT
08-02 DiaSorin: Q2 profitability beat and H2 launches reinforce credibility Alphavalue
07-16 MedTech facing a three-front squeeze Alphavalue
07-07 BNP Paribas Downgrades DiaSorin to Underperform, Reduces PT MT
06-25 Kepler Cheuvreux Begins DiaSorin Coverage with Buy Rating MT
06-22 RBC Capital Raises DiaSorin's PT, Reiterates Outperform Rating MT
06-17 Deutsche Bank Downgrades DiaSorin to Sell, Lowers PT MT
06-11 Piper Sandler Begins Diasorin Coverage with Neutral Rating MT
05-21 DiaSorin: Soft start, loaded H2 Alphavalue
05-11 DiaSorin: Tough quarter, but margins beat and guidance stood firm Alphavalue
05-11 Buy-side prevails on MIB; DiaSorin shows strength AN
04-09 UBS Downgrades DiaSorin to Neutral Rating, Cuts PT MT
03-24 Invest Securities Downgrades DiaSorin to Neutral Rating, Cuts PT MT
03-23 DiaSorin: Lackluster 2026 guidance and execution uncertainty spook investors Alphavalue
03-23 Mediobanca Downgrades Diasorin to Neutral Rating, Cuts PT MT
03-23 Equita SIM Downgrades Diasorin to Hold, Cuts PT MT
12-31 AlphaValue/Baader Europe Lowers DiaSorin's PT, Keeps at Buy MT
12-30 AlphaValue/Baader Europe Cuts Diasorin Price Target, Forecasts Amid Challenges to Near-term Earnings MT
12-30 DiaSorin trims outlook amid market headwinds Alphavalue
11-27 Intesa Sanpaolo Upgrades Diasorin to Buy, Cuts PT MT
11-07 Deutsche Bank Downgrades Diasorin to Hold, Cuts PT MT
11-06 DiaSorin share slump after Q3 earnings miss Alphavalue
11-06 Banca Akros Downgrades Diasorin to Accumulate, Cuts PT MT
25-10-31 DiaSorin receives FDA authorization for Covid and influenza detection kit AN

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+18.95%
+8.13%
-20.34%
+6.53%
+18.63%
+23.12%
-2.55%
+15.93%
Average +8.55%
Weighted average by Cap. +10.16%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
73.54EUR
Average target price
71.66EUR
Spread / Average Target
-2.55%
High Price Target
90.00EUR
Spread / Highest target
+22.38%
Low Price Target
55.00EUR
Spread / Lowest Target
-25.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Intermonte
alphavalue Anas Patel
BNP Paribas
Kepler Cheuvreux
RBC Capital Markets
Deutsche Bank Research
Piper Sandler & Co.
Invest Securities
Mediobanca
Equita SIM
AlphaValue/Baader Europe
Intesa Sanpaolo
Banca Akros (ESN)
JPMorgan
Morgan Stanley
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
73.54EUR
Average target price
71.66EUR
Spread / Average Target
-2.55%

Quarterly revenue - Rate of surprise